Reliance Life Sciences Private recalls

Reliance Life Sciences Private has 4 recalls on record with the FDA and USDA, the earliest in 2026 and the latest reported on 15 Jul 2026. 4 are still ongoing. 4 were reported in the last 12 months. The most frequent reason is sterility.

Total recalls4since 2026

Last 12 months4reported

Class I00% of total

Ongoing4latest 15 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 4Jul 0 0

Severity split

Class I 0 0%Class II 4 100%Class III 0 0%

Why reliance life sciences private is recalled

Sterility4100%

Product types

Injectable & IV Drugs4100%

By year

20264100%

Ongoing reliance life sciences private recalls

4 active

Reported	Class	Recall	Company	Reason	Where
15 Jul 2026Drug	CLASS II	Azacitidine for Injection 100mg/Vial-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
15 Jul 2026Drug	CLASS II	Pemetrexed for Injection 100mg/Vial-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
15 Jul 2026Drug	CLASS II	Bortezomib for Injection 5mg/Vial per Single-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
15 Jul 2026Drug	CLASS II	Pemetrexed for Injection 500mg/Vial-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide

All reliance life sciences private recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
15 Jul 2026Drug	CLASS II	Azacitidine for Injection 100mg/Vial-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
15 Jul 2026Drug	CLASS II	Pemetrexed for Injection 100mg/Vial-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
15 Jul 2026Drug	CLASS II	Bortezomib for Injection 5mg/Vial per Single-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide
15 Jul 2026Drug	CLASS II	Pemetrexed for Injection 500mg/Vial-Dose Vial recalled	Reliance Life Sciences Private	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.